共 62 条
- [1] Ferlay J., Soerjomataram I., Ervik M., Et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet], (2013)
- [2] Access to cancer treatment. A study of medicine pricing issues with recommendations for improving access to cancer medicine. A report prepared for OXFAM [Internet]
- [3] Pakzad H., Mohammadian-Hafshejani A., Ghoncheh M., Et al., The Incidence and mortality of prostate cancer and its relationship with development in Asia, Prostate Int, 3, pp. 135-140, (2015)
- [4] Jeffreys M., Sarfati D., Stevanovic V., Et al., Socioeconomic inequalities in cancer survival in New Zealand: The role of extent of disease at diagnosis, Cancer Epidemiol Biomarkers Prev, 18, pp. 915-921, (2009)
- [5] Torre L.A., Bray F., Siegel R.L., Et al., Global cancer statistics, 2012, CA Cancer J Clin, 65, pp. 87-108, (2015)
- [6] Forman D., Bray F., Brewster D.H., Et al., Cancer Incidence in Five Continents, Vol. X (electronic version)
- [7] Ferlay J., Soejomataram I., Dikshit R., Et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, pp. E359-E386, (2014)
- [8] Parkin D., Ferlay J., Curado M.P., Et al., Cancer incidence in five continents, Int J Cancer, 127, pp. 2918-2927, (2010)
- [9] Hebert J., Daguise V., Hurley D., Et al., Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a high-risk population, Cancer, 115, pp. 2539-2552, (2009)
- [10] Asadzadeh Vostakolaei F., Karim-Kos H., Janssen-Heijnen M., Et al., The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival, Eur J Public Health, 21, pp. 573-577, (2010)